A
Power Law company profile
ADMA Biologics
Biotech & Life Sciences · Ramsey, United States · Founded 2004 · IPO 2013 Unicorn
Valuation
$2.45B
Market cap · Apr/2026
Revenue
$510M
Latest reported FY
Global footprint
Where ADMA Biologics has talent and traffic
Web traffic by country
13K
monthly visits
across markets
across markets
🇺🇸 United States76.2%
🇦🇺 Australia13.8%
🇬🇧 United Kingdom9.2%
🇨🇦 Canada8.5%
🇮🇳 India7.7%
Patent intelligence
$44M patent portfolio · 9 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$44M
1.8% of market cap · 2.9× smaller than top peer Vir Biotechnology ($126M)
9 active patent families
Where ADMA Biologics innovates
VirologyAntibody titerPassive ImmunizationsBlood plasmaGlobulin
Above peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
ADMA Biologics on the five Patsnap quality dimensions
ADMA Biologics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where ADMA Biologics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across ADMA Biologics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee ADMA Biologics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.